Laura Ryan Takes the Helm as Joint Commission's Marketing Lead
Laura Ryan Joins Joint Commission as Chief Marketing Officer
Joint Commission has announced the appointment of Laura Ryan as its Chief Marketing and Communications Officer, effective soon. Ryan brings a wealth of experience in both healthcare and corporate communications to this crucial role. With over 25 years in the industry, she previously held a significant position at Ruder Finn, where she led U.S. Corporate Communications.
Jonathan B. Perlin, MD, PhD, president and CEO of Joint Commission, expressed his confidence in Ryan's capabilities, stating, "Joint Commission has set the standard for healthcare quality and safety for decades. However, the healthcare landscape today is more dynamic and complex than ever. We recognize the importance of effective communication in ensuring all stakeholders understand and appreciate our mission to enhance healthcare quality and safety. Laura's extensive experience in brand positioning and strategic communications makes her an ideal fit for this role. We are excited to have her onboard to help us articulate our story more effectively."
Strategic Vision and Leadership
Reporting to Dr. Perlin, Ryan will oversee a broad range of marketing, branding, and communication initiatives. Her responsibilities will encompass enhancing internal and external communications, developing digital marketing strategies, and engaging stakeholders effectively. Ryan emphasizes that her mission is to make Joint Commission's standards and quality improvement resources more accessible and comprehensible throughout the healthcare community.
Exciting Leadership Opportunity
In her own words, Ryan described her new role as particularly exciting, noting, "Joining Joint Commission at this stage is exhilarating, especially as the organization evolves its role in the future of healthcare both in the U.S. and globally. This organization has a profound impact on patient care and safety, and being part of a team that is mission-driven and reshaping the future of healthcare quality is immensely fulfilling."
Ryan's Background in Healthcare Communication
Before her tenure at Ruder Finn, Ryan held senior positions in corporate communications at Cohn & Wolfe and engaged with top-tier clients at Ketchum and Burson-Marsteller. Her career reflects a deep commitment to healthcare communications, working with renowned pharmaceutical companies and major health systems such as Cleveland Clinic, Biogen, Sanofi, Boehringer Ingelheim, and Takeda Pharmaceuticals. Her extensive experience equips her with a unique perspective on the industry's intricacies and challenges.
In-House Experience and Education
Moreover, Ryan has gained invaluable insights from her roles at the Blue Cross and Blue Shield Association and the American Osteopathic Association, where she navigated healthcare operations and varied regulatory environments. She holds a bachelor’s degree in journalism and political science from the University of Iowa and a master’s degree in communications from Northwestern University. Ryan's robust educational background complements her professional experience, enabling her to lead Joint Commission adeptly.
About Joint Commission
Established in 1951, Joint Commission is the oldest and largest standards-setting and accrediting body in healthcare within the U.S. With the mission to affirm the highest standards of healthcare quality and patient safety for all, Joint Commission evaluates over 23,000 healthcare organizations and programs. As an independent, nonprofit body, it inspires healthcare entities across various sectors to excel in delivering safe and high-quality care.
Inspiring Excellence in Healthcare
Joint Commission continually encourages healthcare organizations to innovate and improve. Through its rigorous accreditation processes, the organization ensures that care delivered is effective, safe, and of the highest value. Ryan's leadership is expected to contribute significantly to this mission, enhancing communication strategies that reflect the organization's commitments to quality and safety.
Frequently Asked Questions
Who is Laura Ryan?
Laura Ryan is the newly appointed Chief Marketing and Communications Officer at Joint Commission, bringing extensive experience in healthcare communications.
What will Laura Ryan's role entail?
She will lead all marketing, branding, and communications initiatives, focusing on enhancing stakeholder engagement and making standards more accessible.
What is Joint Commission's mission?
Joint Commission aims to affirm high standards of healthcare quality and safety, evaluating numerous healthcare organizations across the United States.
When did Laura Ryan start her new position?
Laura Ryan's appointment as Chief Marketing and Communications Officer is effective soon.
What previous experience does Laura Ryan have?
Ryan has over 25 years in the communications field, working with notable firms and healthcare organizations throughout her career.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
